GPC3 and hepatocellular carcinoma: In response to this controversy, Yang SL et al. carried out a meta-analysis of 22 studies for HCC diagnosis by sGPC3 levels, and 18 studies showed that serum GPC3 was a specific biomarker for HCC, with a sensitivity and specificity in combination with other markers of 69% and 93% 85, respectively.